In the MUSE classification of gastroesophageal reflux disease (GERD), esoph
agitis is assessed by the presence of metaplasia, ulcer stricture, or erosi
on, each being graded as absent, mild or severe. Daily reflux symptoms affe
ct about 4 to 7 percent of the population; erosive esophagitis occurs in ab
out 2 percent; the prevalence rate of Barrett's metaplasia is 0.4 percent;
and esophageal adenocarcinoma lends to two deaths per million living popula
tion. In persons with GERD symptoms, about 20 percent are found to have ero
sive esophagitis, while ulcers or strictures are found in less than 5 perce
nt of all patients with erosive esophagitis. No clear-cut temporal progress
ion exists between successive grades of disease severity, as the most sever
e grade of GERD is reached at the onset of the disease. Mild forms of GERD
tend to be more common in women than men, while severe GERD characterized b
y erosive esophagitis, esophageal ulcer; stricture or Barrett's metaplasia
are far more common irt men than women. All forms of GERD affect Caucasians
more often than African Americans or Native Americans. The prevalence of G
ERD is high among developed countries irt North America and Europe and rela
tively low in developing countries in Africa and Asia. During the past thre
e decades, hospital discharges and mortality rates of gastric cancer gastri
c ulcer and duodenal ulcer have declined, while those of esophageal adenoca
rcinoma and GERD have markedly risen. These opposing time trends suggest th
at corpus gastritis secondary to Helicobacter pylori infection protects aga
inst GERD. This hypothesis is consistent with the geographic and ethnic dis
tributions of GERD. Case-control studies also indicate that cases with eros
ive esophagitis are less likely to harbor active or chronic corpus gastriti
s than controls without esophagitis.